These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9328626

  • 1. Opioid receptor affinity and analgesic activity of O- and C-glycosylated opioid peptides.
    Negri L, Melchiorri P, Rocchi R, Scolaro B.
    Acta Physiol Hung; 1996; 84(4):441-3. PubMed ID: 9328626
    [Abstract] [Full Text] [Related]

  • 2. Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration.
    Negri L, Lattanzi R, Tabacco F, Scolaro B, Rocchi R.
    Br J Pharmacol; 1998 Aug; 124(7):1516-22. PubMed ID: 9723966
    [Abstract] [Full Text] [Related]

  • 3. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
    Traynor JR, Guo L, Coop A, Lewis JW, Woods JH.
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1093-9. PubMed ID: 10565829
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S, Kezar HS, Carter RL, Saini SK, Rice KC, Wells JL, Davis P, Xu H, Dersch CM, Bilsky EJ, Porreca F, Rothman RB.
    J Med Chem; 1999 Sep 09; 42(18):3527-38. PubMed ID: 10479286
    [Abstract] [Full Text] [Related]

  • 5. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN, Walker EA.
    J Pharmacol Exp Ther; 2003 Jan 09; 304(1):301-9. PubMed ID: 12490605
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of intracellular calcium in modification of mu and delta opioid receptor-mediated antinociception by diabetes in mice.
    Ohsawa M, Nagase H, Kamei J.
    J Pharmacol Exp Ther; 1998 Aug 09; 286(2):780-7. PubMed ID: 9694934
    [Abstract] [Full Text] [Related]

  • 10. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
    Lattanzi R, Negri L, Giannini E, Schmidhammer H, Schutz J, Improta G.
    Br J Pharmacol; 2001 Sep 09; 134(2):441-7. PubMed ID: 11564664
    [Abstract] [Full Text] [Related]

  • 11. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S, Khare NK, Saini SK, Seitz LE, Bartlett JL, Davis P, Dersch CM, Porreca F, Rothman RB, Bilsky EJ.
    J Med Chem; 2004 Mar 11; 47(6):1400-12. PubMed ID: 14998329
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May 11; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    Neilan CL, Husbands SM, Breeden S, Ko MC, Aceto MD, Lewis JW, Woods JH, Traynor JR.
    Eur J Pharmacol; 2004 Sep 19; 499(1-2):107-16. PubMed ID: 15363957
    [Abstract] [Full Text] [Related]

  • 15. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity.
    DeHaven-Hudkins DL, Burgos LC, Cassel JA, Daubert JD, DeHaven RN, Mansson E, Nagasaka H, Yu G, Yaksh T.
    J Pharmacol Exp Ther; 1999 Apr 19; 289(1):494-502. PubMed ID: 10087042
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
    Bilsky EJ, Qian X, Hruby VJ, Porreca F.
    J Pharmacol Exp Ther; 2000 Apr 19; 293(1):151-8. PubMed ID: 10734164
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and antinociceptive effects of endomorphin-1 analogs with C-terminal linked by oligoarginine.
    Wang CL, Guo C, Wang YQ, Zhou Y, Li Q, Ni JM, Wang R.
    Peptides; 2011 Feb 19; 32(2):293-9. PubMed ID: 21055434
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.